EFEMP1 and lung carcinoma: The findings of the present study revealed significantly lower circulating and local fibulin-3 expression levels in patients with lung cancer than in those with benign lung lesions, with non-significant differences in serum fibulin-3 levels with respect to histological type and no significant correlation to the stage of lung cancer.